Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 July 2007, Vol. 110, No. 1, pp. 45-53.
Prepublished online as a Blood First Edition Paper on March 14, 2007; DOI 10.1182/blood-2006-12-061234.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-12-061234v1
110/1/45    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldenberg, N. A.
Right arrow Articles by Manco-Johnson, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldenberg, N. A.
Right arrow Articles by Manco-Johnson, M. J.
Related Collections
Right arrow Hemostasis, Thrombosis, and Vascular Biology
Right arrow Free Research Articles
Right arrow Clinical Trials and Observations
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CLINICAL TRIALS AND OBSERVATIONS

A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children

Neil A. Goldenberg1,3, Janette D. Durham4, R. Knapp-Clevenger5, and Marilyn J. Manco-Johnson1,2

1 University of Colorado at Denver and Health Sciences Center, Department of Pediatrics, Section of Hematology/Oncology/Bone Marrow Transplantation and the Center for Cancer and Blood Disorders, The Children's Hospital, Denver; 2 Mountain States Regional Hemophilia and Thrombosis Center, Aurora, CO; 3 University of Colorado at Denver and Health Sciences Center, Department of Internal Medicine, Division of Hematology/Oncology, Denver; 4 University of Colorado at Denver and Health Sciences Center, Department of Radiology, Division of Interventional Radiology, Denver; 5 University of Colorado at Denver and Health Sciences Center, Department of Pediatrics and the Pediatric Clinical Translational Research Center, The Children's Hospital, Denver, CO

Important predictors of adverse outcomes of thrombosis in children, including postthrombotic syndrome (PTS), have recently been identified. Given this knowledge and the encouraging preliminary pediatric experience with systemic thrombolysis, we sought to retrospectively analyze our institutional experience with a thrombolytic regimen versus standard anticoagulation for acute, occlusive deep venous thrombosis (DVT) of the proximal lower extremities in children in whom plasma factor VIII activity and/or D-dimer concentration were elevated at diagnosis, from within a longitudinal pediatric cohort. Nine children who underwent the thrombolytic regimen and 13 who received standard anticoagulation alone were followed from time of diagnosis with serial clinical evaluation and standardized PTS outcome assessments conducted in uniform fashion. The thrombolytic regimen was associated with a markedly decreased odds of PTS at 18 to 24 months compared with standard anticoagulation alone, which persisted after adjustment for significant covariates of age and lag time to therapy (odds ratio [OR] = 0.018, 95% confidence interval [CI] = < 0.001-0.483; P = .02). Major bleeding developed in 1 child, clinically judged as not directly related to thrombolysis for DVT. These findings suggest that the use of a thrombolysis regimen may safely and substantially reduce the risk of PTS in children with occlusive lower-extremity acute DVT, providing the basis for a future clinical trial.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Clot busting in kids: less PTS?
Leslie Raffini
Blood 2007 110: 4-5. [Full Text] [PDF]



This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
N. A Goldenberg, L. Jacobson, H. Hathaway, M. Tripputi, J. Primeaux, and J. Child
Anti-Xa Stability of Diluted Dalteparin for Pediatric Use
Ann. Pharmacother., April 1, 2008; 42(4): 511 - 515.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. B. Kinane, E. F. Grabowski, A. Sharma, K. Nimkin, M. E. King, and L. D. Cornell
Case 7-2008 -- A 17-Year-Old Girl with Chest Pain and Hemoptysis
N. Engl. J. Med., February 28, 2008; 358(9): 941 - 952.
[Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020